RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

被引:1759
作者
Yan, SD
Chen, X
Fu, J
Chen, M
Zhu, HJ
Roher, A
Slattery, T
Zhao, L
Nagashima, M
Morser, J
Migheli, A
Nawroth, P
Stern, D
Schmidt, AM
机构
[1] COLUMBIA UNIV COLL PHYS & SURG,DEPT SURG,NEW YORK,NY 10032
[2] COLUMBIA UNIV COLL PHYS & SURG,DEPT PHYSIOL & MED,NEW YORK,NY 10032
[3] SUN HLTH RES INST,SUN CITY,AZ 85372
[4] BERLEX BIOSCI,RICHMOND,CA 94804
[5] UNIV TURIN,I-10126 TURIN,ITALY
[6] UNIV HEIDELBERG,DEPT MED,D-69115 HEIDELBERG,GERMANY
关键词
D O I
10.1038/382685a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Amyloid-beta peptide is central to the pathology of Alzheimer's disease, because it is neurotoxic-directly by inducing oxidant stress, and indirectly by activating microglia. A specific cell-surface acceptor site that could focus its effects on target cells has been postulated but not identified. Here we present evidence that the receptor for advanced glycation end products' (RAGE) is such a receptor, and that it mediates effects of the peptide on neurons and microglia. increased expression of RAGE in Alzheimer's disease brain indicates that it is relevant to the pathogenesis of neuronal dysfunction and death.
引用
收藏
页码:685 / 691
页数:7
相关论文
共 45 条
[31]  
ROHER AE, 1993, J BIOL CHEM, V268, P3072
[32]   ADVANCED GLYCATION ENDPRODUCTS INTERACTING WITH THEIR ENDOTHELIAL RECEPTOR INDUCE EXPRESSION OF VASCULAR CELL-ADHESION MOLECULE-1 (VCAM-1) IN CULTURED HUMAN ENDOTHELIAL-CELLS AND IN MICE - A POTENTIAL MECHANISM FOR THE ACCELERATED VASCULOPATHY OF DIABETES [J].
SCHMIDT, AM ;
HORI, O ;
CHEN, JX ;
LI, JF ;
CRANDALL, J ;
ZHANG, JH ;
CAO, R ;
YAN, SD ;
BRETT, J ;
STERN, D .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (03) :1395-1403
[33]  
SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987
[34]   REGULATION OF HUMAN MONONUCLEAR PHAGOCYTE MIGRATION BY CELL-SURFACE BINDING-PROTEINS FOR ADVANCED GLYCATION END-PRODUCTS [J].
SCHMIDT, AM ;
YAN, SD ;
BRETT, J ;
MORA, R ;
NOWYGROD, R ;
STERN, D .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (05) :2155-2168
[35]   TRANSTHYRETIN SEQUESTERS AMYLOID-BETA PROTEIN AND PREVENTS AMYLOID FORMATION [J].
SCHWARZMAN, AL ;
GREGORI, L ;
VITEK, MP ;
LYUBSKI, S ;
STRITTMATTER, WJ ;
ENGHILDE, JJ ;
BHASIN, R ;
SILVERMAN, J ;
WEISGRABER, KH ;
COYLE, PK ;
ZAGORSKI, MG ;
TALAFOUS, J ;
EISENBERG, M ;
SAUNDERS, AM ;
ROSES, AD ;
GOLDGABER, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (18) :8368-8372
[36]   AVID BINDING OF BETA-A AMYLOID PEPTIDE TO ITS OWN PRECURSOR [J].
STRITTMATTER, WJ ;
HUANG, DY ;
BHASIN, R ;
ROSES, AD ;
GOLDGABER, D .
EXPERIMENTAL NEUROLOGY, 1993, 122 (02) :327-334
[37]   APOLIPOPROTEIN-E - HIGH-AVIDITY BINDING TO BETA-AMYLOID AND INCREASED FREQUENCY OF TYPE-4 ALLELE IN LATE-ONSET FAMILIAL ALZHEIMER-DISEASE [J].
STRITTMATTER, WJ ;
SAUNDERS, AM ;
SCHMECHEL, D ;
PERICAKVANCE, M ;
ENGHILD, J ;
SALVESEN, GS ;
ROSES, AD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (05) :1977-1981
[38]   beta-Amyloid-mediated vasoactivity and vascular endothelial damage [J].
Thomas, T ;
Thomas, G ;
McLendon, C ;
Sutton, T ;
Mullan, M .
NATURE, 1996, 380 (6570) :168-171
[39]  
TROJANOWSKI JQ, 1994, AM J PATHOL, V144, P449
[40]   Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy - Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats [J].
Wautier, JL ;
Zoukourian, C ;
Chappey, O ;
Wautier, MP ;
Guillausseau, PJ ;
Cao, R ;
Hori, O ;
Stern, D ;
Schmidt, AM .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (01) :238-243